Literature DB >> 24667590

Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile.

Dina Kao1, Naomi Hotte, Patrick Gillevet, Karen Madsen.   

Abstract

Inflammatory bowel disease (IBD) is a chronic relapsing disorder of the intestine of unclear etiology. Increasing evidence has pointed to intestinal dysbiosis as a potential factor in a genetically susceptible individual. Fecal microbiota transplantation (FMT) has been used to treat inflammatory bowel disease with variable degrees of success. Herein, we report a patient with Crohn's colitis, previously failing an immunosuppressant, who achieved clinical, endoscopic, and histologic remission after a single fecal microbiota transplantation infusion. We have further characterized the changes in the fecal microbiota associated with this observation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24667590     DOI: 10.1097/MCG.0000000000000131

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  25 in total

Review 1.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 2.  The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.

Authors:  Taha Qazi; Thelina Amaratunga; Edward L Barnes; Monika Fischer; Zain Kassam; Jessica R Allegretti
Journal:  Gut Microbes       Date:  2017-09-12

3.  The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor.

Authors:  Jeffrey D Galley; Zhongtang Yu; Purnima Kumar; Scot E Dowd; Mark Lyte; Michael T Bailey
Journal:  Gut Microbes       Date:  2014

Review 4.  Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.

Authors:  Alexa R Weingarden; Byron P Vaughn
Journal:  Gut Microbes       Date:  2017-02-10

Review 5.  Fecal microbiota transplantation broadening its application beyond intestinal disorders.

Authors:  Meng-Que Xu; Hai-Long Cao; Wei-Qiang Wang; Shan Wang; Xiao-Cang Cao; Fang Yan; Bang-Mao Wang
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 6.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

Review 7.  Harnessing regulatory T cells for the treatment of inflammatory bowel disease.

Authors:  Duke Geem; Akihito Harusato; Kyle Flannigan; Timothy L Denning
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

8.  Minimum Requirements for Reporting Fecal Microbiota Transplant Trial.

Authors:  Shirin Moossavi; Faraz Bishehsari; Reza Ansari; Homayoon Vahedi; Siavosh Nasseri-Moghaddam; Shahin Merat; Iradj Sobhani; Ali Keshavarzian; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2015-07

Review 9.  Mucosal Immune Development in Early Life: Setting the Stage.

Authors:  Sylvia Brugman; Olaf Perdijk; R J Joost van Neerven; Huub F J Savelkoul
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-02-11       Impact factor: 4.291

10.  Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.

Authors:  Bota Cui; Pan Li; Lijuan Xu; Youquan Zhao; Huiquan Wang; Zhaoyuan Peng; Hai'e Xu; Jie Xiang; Zhi He; Ting Zhang; Yongzhan Nie; Kaichun Wu; Daiming Fan; Guozhong Ji; Faming Zhang
Journal:  J Transl Med       Date:  2015-09-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.